Stryker Corporation – FDA 483, Jan 24, 2023
Stryker Corporation in Portage, MI, a medical device establishment, was cited for two significant issues during an FDA inspection. The firm failed to adequately establish procedures for complaint handling, leading to significant delays in reporting MDRs for the C2 Nerve Monitor device, which was subsequently recalled. Additionally, procedures for design validation, particularly for device software, were found to be inadequately established, with issues in defining software units and executing regression testing.
ID · 48536332-c790-438d-925b-1f1e7e3a30ee
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.